Agenda

Sessions:

Thursday, July 18

11:00-1:40 pm

Registration, Check-In, and Exhibits

1:40-1:45 pm

Introduction and Program Overview
Kirkwood F. Adams, Jr., MD

Session I: Current Approaches to the Management of Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD

1:45-2:15 pm

Semaglutide for HFpEF
Mikhail N. Kosiborod, MD

2:15-2:45 pm

ARNI and SGLT2i Therapy for HFpEF
Robert J. Mentz, MD and Javed Butler, MD, MPH

2:45-3:10 pm

Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin A. Konstam, MD

3:10-3:30 pm

Optimizing Polypharmacy in HFpEF: Clinical Phenotypes and Pathophysiology
Moderator: Robert J. Mentz, MD
Panelists:
Javed Butler, MD, MPH, MBA, Marvin A. Konstam, MD, and Kirkwood F. Adams, Jr, MD

3:30-3:45 pm

Break & Exhibits

3:45-4:10 pm

Early Recognition of Heart Failure – Best Definition: Role of Biomarkers and Omics
David E. Lanfear, MD and Peter P. Liu, MD

4:10-4:50 pm

Optimizing Polypharmacy – Closing “Old School – New School” GDMT Treatment Gaps
Moderator: Kirkwood F. Adams, Jr, MD
Speakers:
Stephanie H. Dunlap, DO, Stephen Greene, MD, and Nancy M. Albert, PhD, RN
Panelists: Marvin Konstam, MD, Javed Butler, MD, MPH, MBA, and Alan B. Miller, MD

4:50-5:30 pm

Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters: Douglas D. Schocken, MD
Case Discussants: Nancy M. Albert, PhD, RN, Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, and Sara Paul, DNP

Friday, July 19

7:30-8:00 am

Breakfast, Check-In & Exhibits

Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD

8:00-8:25 am

Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD

8:25-8:40 am

EP Panel Discussion
Discussants:  Alan B. Miller, MD, Anil K. Gehi, MD, and Matthew Baker, MD

Session III: Latest on Surgical and Device Strategies for Advanced Heart Failure
Moderator: Patricia P. Chang, MD, MHS 

8:40-9:00 am

Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
Mirnela Byku, MD, PhD, MBA, MHS 

9:00-9:20 am

Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions
JoAnn Lindenfeld, MD

9:20-9:35 am

Break & Exhibits

9:35-9:55 am

Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD

9:55-10:35 am

Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Moderator: Patricia P. Chang, MD, MHS
Case Presenter: William Mostertz, MD
Panelists: James B. Young, MD, Mirnela Byku MD, PhD, MBA, MHS, Christopher V. Chien, MD, and JoAnn Lindenfeld, MD 

10:35-11:30 am

Featured Panel Discussion: Advanced Heart Failure: Application of Mechanical Circulatory Support and Left Ventricular Assist Devices
Moderator: Patricia P. Chang, MD, MHS
Speaker: James C. Fang, MD, Thomas G. Caranasos, MD, and Navin K. Kapur, MD
Commentary: Mustafa M. Ahmed, MD and Mirnela Byku MD, PhD, MHS

Hot Topic Update on Novel and Investigational Devices for Heart Failure

11:30-12:20 pm

Expert Panel Discussion: Novel and Investigational Devices for Monitoring and Treatment
Moderator: Alan B. Miller, MD
Speakers: William T. Abraham, MD, Marvin A. Konstam, MD, and Marat Fudim, MD, MHS
Panelists: JoAnn Lindenfeld, MD and Christopher V. Chien, MD


Breakout Luncheon Session

12:30-1:30 pm

TBD

1:30-2:30 pm

Concurrent Workshops

Nursing Challenges in Caring for the Chronic Heart Failure Patient
Sarah Waters, ANP-BC, Carrie Neal, RN, BSN, Emily Baker, MSN, AGNP–C, Tonya Carter, DNP, NP-C and Tammy Long, AGNP, MSN

Optimizing Patient Selection for EP Device and Intervention Therapy
Anil K. Gehi, MD, Matthew Baker, MD and Faisal F. Syed, BSc, MBChB

Clinical Application of Biomarkers and Omics in Day to Day Heart Failure Patient Care
Kirkwood F. Adams, Jr., MD, Ileana L. Piña, MD, MPH, and David E. Lanfear, MD

Case-Based Interactive Discussion: How to Do an Effective Heart Failure History and Physical
Douglas D. Schocken, MD

Cardio-Oncology: Clinical Case Discussions
Jo Ellen Rodgers, PharmD and Brian C. Jensen, MD

Saturday, July 20

7:15-8:30 am

Breakfast, Check-In & Exhibits

Session IV: Future Directions in Heart Failure Therapy: Biomarkers, Cardiomyopathy, and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD

9:00-9:30 am

Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role of Novel Drug Therapy
Mathew S. Maurer, MD

9:30-9:40 am

Clinical Discussion of Nuances in the Management of Cardiac Amyloid
Mathew S. Maurer, MD and Alan B. Miller, MD

9:40-10:15 am

Myosin Modulation: Update on the Latest Drugs for Hypertrophic Cardiomyopathy
Anjali Owens, MD

10:15-10:25 am

Clinical Considerations to Optimize the Management of Hypertrophic Cardiomyopathy
Anjali Owens, MD and Kirkwood F. Adams, Jr., MD   

10:25-10:40 am

Break & Exhibits

10:40-11:10 am

Latest Approaches to Treatment of Worsening Heart Failure
Stephen Greene, MD

11:10-11:55 am

Late Breaking HF Trial Results
Moderator: Robert J. Mentz, MD
Speakers:
Renal Benefits of Pharmacotherapy in Congestive Heart Failure – JoAnn Lindenfeld, MD
Semaglutide for HFpEF with Obesity – Javed Butler, MD, MPH, MBA

11:55-12:20 pm

Update on Novel Therapeutic Approaches to Heart Failure
Kirkwood F. Adams, MD and Barry Greenberg, MD

12:20-12:30 pm

Lunch Pick-Up

12:30-1:30 pm

Breakout Luncheon – Featured Panel

Expert Panel Discussion:  Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Christopher M. O’Connor, MD and Larry Allen, MD
Panelists: Javed Butler, MD, MPH, MBA, JoAnn Lindenfeld, MD, Ileana L. Piña, MD, MPH, Stephen Greene, MD, and Mona Fiuzat, PharmD

1:30-2:30 pm

Concurrent Workshops

Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Erika Schoenborn, PharmD, and Barry E. Bleske, PharmD

Treating Advanced and Refractory HF: Optimizing Pre-Op and Post-OP LVAD Care
Robert T. Cole, MD, Lauren B. Cooper, MD, Elizabeth Volz, MD, Stephanie H. Dunlap, DO, Evan Hiner, MD, and Megan Andrews, MSN, APRN, ANP-C

Unusual Cardiomyopathies: Approaches to Evaluation and Management
Mirnela Byku, MD, PhD, MBA, Mathew S. Maurer, MD, Anjali Owens, MD, and Uri Elkayam, MD

Optimizing Device Therapy for HFrEF
Faisal F. Syed, BSc, MBChB and Marat Fudim, MD, MHS

Novel Approaches to Pharmacological and Device Therapy to Control Congestion in Heart Failure
William T. Abraham, MD

Sunday, July 21

7:30-8:00 am

Continental Breakfast, Check-In & Exhibits

Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD

8:00-8:30 am

Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH

8:30-9:20 am

The Team Approach to Heart Failure Patient Management
Moderator: Ileana L. Piña, MD, MPH
Panel Discussion: Tammy Long, AGNP, Erika Schoenborn, PharmD, Katherine Di Palo, PharmD, Carrie Neal, RN, BSN, and Sarah Waters, ANP-BC

9:20-9:45 am

Advancing the Cardiovascular Care of the Oncology Patient
Brian C. Jensen, MD

9:45-10:10 am

Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose-Jones, MD

10:10-10:30 am

Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD

10:30-10:55 am
Atrial Fibrillation: Consequences and Therapeutic Implications in CHF

Anil K. Gehi, MD

10:55-11:15 am

Current Clinical Approaches to Important Co-morbidities in Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
Panel Discussion:
Lisa J. Rose-Jones, MD, Brian C. Jensen, MD, Anil K. Gehi, MD, and William G. Cotts, MD

11:15-12:00 pm

Heart Failure Management Forum: Case-Based Strategies to Optimize Decision Making in CHF Care
Moderators: Ileana L. Piña, MD, MPH and Kirkwood F. Adams, Jr., MD

12:00 pm

ADJOURN